A patient with implanted cardiac pacemaker may be a candidate for BNCT. In this paper, a phan tom study was performed to evaluate the effect of an epithermal neutron beam irradiation on the car diac pacemaker function. The neutron and photon doses at pacemaker typical location were calcu lated with the SERA treatment planning system for a typical neck area tumor patient. Approximately similar irradiation conditions were reproduced in a large water phantom computed using the MCNP5 program. Two cardiac pacemaker models were irradiated with the FiR 1 epithermal neutron beam. The neutron fl uences were determined at the pacemaker locations using diluted Mn and Au activa tion foils. The photon dose was determined using a Mg(Ar) ionization chamber. Severe malfunction occurred in case of both pacemakers. Both pacemakers got activated, the main detected radionuclides being 198 Au, 128 I, 194 Ir, 56 Mn, 38 Cl and 187 W with half-lives from 25 minutes to 2.7 days. These results suggest that substantially lower dose from epithermal neutron irradiation causes permanent damage or severe malfunction in the pacemaker than has been observed in the fast neutron or photon beam irradiations at the same photon dose rate level. In addition, pacemaker components get activated in the epithermal neutron beam irradiation causing additional radiation dose to the patient and risk of unexpected memory changes in the pacemaker's microprocessor that may cause malfunction to the device also after BNCT irradiation. Thus BNCT should be administrated only after removal of the pacemaker from the vicinity of the tumor.
Introduction
A patient with implanted cardiac pacemaker may be a candidate for BNCT. Radiation may cause permanent damage or temporary malfunctions on semiconductor materials found in pacemakers. For the safe pacemaker functioning during photon radiotherapy, it has been suggested, that the pacemaker should not be placed in the direct therapy beam and the cumulative dose to pacemaker is limited to 2 Gy (Marbach et al. 1994) . Wide photon dose rage (0.5-40 Gy) has reported to affect pacemaker function (Tondato et al. 2009 , Oshiro et al. 2008 . Permanent damage can occur to a pacemaker after exposure to 10 Gy in a photon beam irradiation (Last 1998 , Marbach et al 1994 . Maximum tolerable cumulative radia tion dose for safe operation of pacemakers depends highly on pacemaker type and model as well as on the dose rate (Mouton et al. 2002) . Modern pacemakers with complimentary metal oxide semiconductor (CMOS) cir cuits are more radiosensitive than older pace makers with nonprogrammable bipolar semi conductors (Solan et al. 2004 ). For the modern pacemakers in a high-energy photon beam irradiation, a maximum dose rate of 12 Gy/h rejecting direct irradiation of the pace maker is recommended for the safe operation of pacemakers, while no malfunction has been observed with the dose rates lower than 3 Gy/h (Mouton et al. 2002) . Usual recommendation of the pacemaker manufacturers is that the total cumulative dose should never exceed 5 Gy. Protons and neutrons with densely ionizing tracks are more likely to cause damage than photons. Minor pacemaker changes have been detected during proton beam therapy caused by scattered neutrons (Oshiro et al. 2008) . Catastrophic pacemaker malfunction has been reported during fast neutron therapy at a dose of only 0.9 Gy (Raitt et al. 1994) . The pacemaker was not perma nently damaged due to 0.9 Gy fast neutron dose, but its programming code was signifi cantly corrupted. Interference of a neutron beam used for BNCT with a pacemaker has not yet been reported in the literature. A phantom study was performed to evaluate im pact of an epithermal neutron beam irradiation on the cardiac pacemaker function. 
Epithermal Neutron Beam Interference with Cardiac Pacemakers

Materials and Methods
Neutron fl uence and photon dose at typical pacemaker location was calculated with the SERA treatment planning system for a neck area tumor patient. At the pacemaker located at 10 cm distance from the beam aperture edge at about 0.5 cm depth under skin maximum fl uence rate of thermal (E < 0.414 eV) neutrons was 1.8 × 10 8 neutrons/cm 2 /s, epithermal (0.414 eV < E < 9.12 keV) neutrons 1.8 × 10 8 neutrons/cm 2 /s and fast neutrons (E > 9.12 keV) 8.2 × 10 6 neutrons/ cm 2 /s. The maximum fast neutron dose rate calculated in soft tissue (10.1 w-% of hydrogen and 2.6 w-% of nitro gen) was 0.1 Gy/h and maximum thermal neutron dose (due to nitrogen capture) 0.3 Gy/h. Maximum photon dose rate at the pace maker location was 1.3 Gy/h. Approximately similar irradiation conditions were reproduced in a water phantom. A large (51 cm ×51 cm ×47 cm) cubical water phantom with 1 cm thick PMMA walls and 0.5 cm thick beam side window (Ø 30 cm) was applied. Two cardiac pacemaker models (Verity ADx XL DR 5356 and Zephyr DR 5820) of St Jude Medical were tested in the FiR 1 epi thermal neutron beam. Both models are of modern type using CMOS circuitry. The pacemakers were attached on the 0.5 cm thick phantom inner wall at 9 cm (Zephyr) and 13 cm (Verity) off the 14 cm diameter beam central axis ( Figure 1 ). The phantom was placed at the 10 cm distance from the beam aperture plane.
The predicted neutron fl uences as well as the total neutron and photon doses in water calculated using MCNP5 at the pacemaker locations are shown in table I. Tally F4 was used to determine the fl uences and tally F6 the doses. Pacemaker structures were not modeled, since exact elemental composition and structures inside the pacemakers are com pany confi dential information and thus not available from the manufacturer. Thus pace makers were modeled as 0.5 cm thick cylindri cal water discs with 1.5 cm radius. In order to verify the MCNP5 calculations, the neutron fl uence was determined at the pacemaker location using diluted MnAl and AuAl activation foils with 1 w-% of manganese and gold. The reaction rates were calculated with MCNP5 using 0.1 cm thick cylindrical tally volumes of 0.5 cm radius and the F4 tally with the tally multiplier card scoring the total number of (n,γ) reactions in manganese and gold. The photon dose was measured using a Mg(Ar) ionization chamber of Exradin. The ionization chamber was placed behind and between the pacemakers touching them, at 11 cm off the beam central axis as shown in fi g ure 1. At that location, the chamber measures dose at about 2 cm behind the pacemakers. The pacemakers were irradiated for an hour, which is about a typical duration of the two-fi eld neck tumor BNCT treatment at FiR 1. The pacemakers were interrogated be fore and after irradiation, when the pulse vol tages and intervals generated by the pace makers were measured. Also, pacemaker neutron activation itself was measured.
Results and Discussion
Severe malfunction was detected in case of both pacemakers after the irradiation. Verity went into 'Back-Up mode VVI' due to multi ple unexpected memory changes in micro processor, meaning that the backup program had turned safe pacing rate on. Zephyr lost it's ID bit and cleared the registry due to many severe bit fl ips. It was impossible to interro gate the device after the irradiation. The both pacemakers got activated due to several nuclides listed in table II. Most of these nuclides are also β active. The measured dose rate on the pacemaker sur face immediately after the irra diation was 400 µSv/h for the Zephyr and 150 µSv/h for the Verity. Calculated 55 Mn(n,γ) and 197 Au(n,γ) reaction rates agreed with the measurements within 13% and 9% respectively. The measured photon dose was 2.6 Gy and the calculated using MCNP5 1.9 Gy at the measurement location. The calculated photon doses at the pacemaker locations were 2.0 Gy and 1.2 Gy. If the actual photon dose would had been 33% greater, as may be suggested based on the measurement, the actual photon doses at the pacemaker sites would had been 2.7 Gy and 1.6 Gy, with corresponding dose rates of 3.0 and 1.8 Gy/h. Permanent pacemaker malfunctions has been reported at a dose below 2 Gy in a photon beam only if the dose is delivered with a dose rate above 30 Gy/h (Mouton et al. 2002 ). In the same study, none of the 96 irradiated pacemakers failed at a dose rate lower than 12 Gy/h. At 18 MeV photon beam energy, neutrons may play partial role in the radiation damage. At lower (6 MV-10 MV) photon beam energies, permanent pacemaker failure has not been detected at cumulative doses below 10 Gy (Last 1998) . Absorbed neutron dose in the pacemaker is material dependent and thus, exact neutron dose esti mation is diffi cult. In this study, we have reported the absorbed dose calculated in water at the pacemaker location. The calculated epithermal and thermal neutron fl uence rate at the pacemaker locations was almost 100 times that of fast neutron fl uence. The neutron fl uence spectra at the pacemaker locations are shown in fi gure 2.
mainly due to neutron activation of the pacemaker struc tures, since the β-active radionuclides may cause changes in semiconductors inside the device.
Conclusions
These results suggest that already low neutron dose from epithermal neutron irradiation causes pacemaker malfunction, and thus BNCT should be administrated only after removal and replacement of the pacemaker from the vicinity of the tumor. In addition, pacemaker components get activated in the BNCT beam causing additional radiation dose to patient and risk of unexpected memory changes in the pacemaker's microprocessor that may cause malfunction to the device also after BNCT irradiation.
The calculated total neutron doses (0.2 Gy and 0.1 Gy) to the pacemakers are substantially lower than the fast neutron dose (0.9 Gy) reported to cause pacemaker mal function, not permanent damage. Also, deter mined cumulative photon dose at the Zephyr pacemaker site is substantially lower (2.7 Gy) than the photon doses reported to cause per manent failure (dose limit 10 Gy) at the simi lar dose rate level. We suggest that the ob served pacemaker malfunction is Table II . Major neutron activated radionuclides detected using a HPGE gamma spectrometer after pacemaker irradiation, half-lives (T 1/2 ) and energies of the principal gammas (Eγ).
